CART peptide: Central mediator of leptin-induced adipose tissue apoptosis?

Regulatory Peptides

Volumn 121, Issue 1-3, 2004, Pages 155-162

  Choi, Yang Ho ^a   Della Fera, Mary Anne ^a   Li, Changlong ^a   Hartzell, Diane L ^a   Little, Dianne E ^a   Kuhar, Michael J ^b   Baile, Clifton A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Body weight; Cerebral ventricular infusion; Feeding behavior; Physical activity; Rats

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; FATTY ACID; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CEREBROSPINAL FLUID; CONTROLLED STUDY; EPIDIDYMIS FAT; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GASTROCNEMIUS MUSCLE; HYPOTHERMIA; MALE; MEAL; MUSCLE MASS; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; RETROPERITONEUM; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BODY TEMPERATURE; BODY WEIGHT; DRINKING; EATING; FATTY ACIDS, NONESTERIFIED; FEEDING BEHAVIOR; INSULIN; LEPTIN; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; ORGAN SIZE; RATS;

EID: 3142562244     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.05.001     Document Type: Article

References (47)

1. Gautvik K.M., de Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A., et al. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8733-8738
2. Dall Vechia S., Lambert P.D., Couceyro P.C., Kuhar M.J., Smith Y. CART peptide immunoreactivity in the hypothalamus and pituitary in monkeys: analysis of ultrastructural features and synaptic connections in the paraventricular nucleus. J. Comp. Neurol. 416:2000;291-308
3. Koylu E.O., Couceyro P.R., Lambert P.D., Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol. 391:1998;115-132
4. Koylu E.O., Couceyro P.R., Lambert P.D., Ling N.C., DeSouza E.B., Kuhar M.J. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J. Neuroendocrinol. 9:1997;823-833
5. Vrang N., Tang-Christensen M., Larsen P.J., Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res. 818:1999;499-509
6. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:1998;72-76
7. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:1998;293-298
8. Larsen P.J., Vrang N., Petersen P.C., Kristensen P. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes. Res. 8:2000;590-596
9. Elias C.F., Lee C., Kelly J., Aschkenasi C., Ahima R.S., Couceyro P.R., et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron. 21:1998;1375-1385
10. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., Sivitz W.I. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100:1997;270-278
11. Wang C., Billington C.J., Levine A.S., Kotz C.M. Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. NeuroReport. 11:2000;3251-3255
12. Gullicksen P.S., Flatt W.P., Dean R.G., Hartzell D.L., Baile C.A. Energy metabolism and expression of uncoupling proteins 1, 2 and 3 after twenty-one days of recovery from mouse leptin ICV in rats. Physiol. Behav. 75:2002;473-482
13. Gullicksen P.S., Hausman D.B., Dean R.G., Hartzell D.L., Baile C.A. Adipose tissue cellularity and apoptosis after intracerebroventricular injections of leptin and 21 days of recovery in rats. Int. J. Obes. 27:2003;302-312
14. Della-Fera M.A., Qian H., Baile C.A. Adipocyte apoptosis in the regulation of body fat mass by leptin. Diabetes Obes. Metab. 3:2001;299-310
15. Choi Y.H., Li C.L., Page K.A., Westby A., Della-Fera M.A., Lin J., et al. Melanocortin receptors mediate leptin effects on feeding and body weight, but not adipose apoptosis. Physiol. Behav. 79:2003;795-801
16. Gullicksen P.S., Dean R.G., Baile C.A. Detection of DNA fragmentation and apoptotic proteins, and quantification of uncoupling protein expression by real-time RT-PCR in adipose tissue. J. Biochem. Biophys. Methods. 58:2004;1-13
17. Aja S., Sahandy S., Ladenheim E.E., Schwartz G.J., Moran T.H. Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site. Am. J. Physiol., Regul. Integr. Comp. Physiol. 281:2001;R1862-R1867
18. Abbott C.R., Rossi M., Kim M., AlAhmed S.H., Taylor G.M., Ghatei M.A., et al. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor. Brain Res. 869:2000;203-210
19. Chaki S., Kawashima N., Suzuki Y., Shimazaki T., Okuyama S. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur. J. Pharmacol. 464:2003;49-54
20. Qian H., Azain M.J., Compton M.M., Hartzell D.L., Hausman G.J., Baile C.A. Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology. 139:1998;791-794
21. Page K.A., Hartzell D.L., Li C., Westby A.L., Della-Fera M.A., Azain M.J., Pringle T.D., Baile C.A. Beta-adrenergic receptor agonists increase apoptosis of adipose tissue in mice. Domest. Anim. Endocrinol. 26:2004;23-31
22. del Giudice E.M., Santoro N., Cirillo G., D'Urso L., Di Toro R., Perrone L. Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes. 50:2001;2157-2160
23. Yamada K., Yuan X., Otabe S., Koyanagi A., Koyama W., Makita Z. Sequencing of the putative promoter region of the cocaine- and amphetamine-regulated-transcript gene and identification of polymorphic sites associated with obesity. Int. J. Obes. Relat. Metab. Disord. 26:2002;132-136
24. Asnicar M.A., Smith D.P., Yang D.D., Heiman M.L., Fox N., Chen Y.F., et al. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology. 142:2001;4394-4400
25. Broberger C. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res. 848:1999;101-113
26. Dallvechia-Adams S., Smith Y., Kuhar M.J. CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J. Comp. Neurol. 434:2001;29-39
27. Dallvechia-Adams S., Kuhar M.J., Smith Y. Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J. Comp. Neurol. 448:2002;360-372
28. Ekblad E., Kuhar M., Wierup N., Sundler F. Cocaine- and amphetamine-regulated transcript: distribution and function in rat gastrointestinal tract. Neurogastroenterol. Motil. 15:2003;545-557
29. Tsuruta Y., Yoshimatsu H., Hidaka S., Kondou S., Okamoto K., Sakata T. Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression. Am. J. Physiol. Endocrinol. Metab. 282:2002;E967-E973
30. Wang Z.W., Zhou Y.T., Kakuma T., Lee Y., Higa M., Kalra S.P., et al. Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10373-10378
31. Adams L.D., Gong W., Vechia S.D., Hunter R.G., Kuhar M.J. CART: from gene to function. Brain Res. 848:1999;137-140
32. Kong W.M., Stanley S., Gardiner J., Abbott C., Murphy K., Seth A., et al. A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J. 17:2003;1688-1690
33. Abbott C.R., Rossi M., Wren A.M., Murphy K.G., Kennedy A.R., Stanley S.A., et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology. 142:2001;3457-3463
34. Aja S., Robinson B.M., Mills K.J., Ladenheim E.E., Moran T.H. Fourth ventricular CART reduces food and water intake and produces a conditioned taste aversion in rats. Behav. Neurosci. 116:2002;918-921
35. Schwartz M.W., Baskin D.G., Bukowski T.R., Kuijper J.L., Foster D., Lasser G., et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:1996;531-535
36. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123
37. Balasko M., Szelenyi Z., Szekely M. Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol. Hung. 86:1999;219-222
38. Itoh S., Hirota R. Effect of intraventricular administration of vasoactive intestinal polypeptide on body temperature in the rat. Jpn. J. Physiol. 32:1982;677-681
39. Itoh S., Takashima A., Itoh T., Morimoto T. Effects of neuromedins and related peptides on the body temperature of rats. Jpn. J. Physiol. 45:1995;37-45
40. Nemeroff C.B., Bissette G., Prange A.J. Jr., Loosen P.T., Barlow T.S., Lipton M.A. Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res. 128:1977;485-496
41. Tsushima H., Mori M., Fujiwara N., Moriyama A. Pharmacological characteristics of bombesin receptor mediating hypothermia in the central nervous system of rats. Brain Res. 969:2003;88-94
42. Avery D.D., Calisher S.B. The effects of injections of bombesin into the cerebral ventricles on food intake and body temperature in food-deprived rats. Neuropharmacology. 21:1982;1059-1063
43. Ruiz de Elvira M.C., Coen C.W. Centrally administered neuropeptide Y enhances the hypothermia induced by peripheral administration of adrenoceptor antagonists. Peptides. 11:1990;963-967
44. Bouali S.M., Fournier A., St-Pierre S., Jolicoeur F.B. Effects of NPY and NPY2-36 on body temperature and food intake following administration into hypothalamic nuclei. Brain Res. Bull. 36:1995;131-135
45. Jolicoeur F.B., Michaud J.N., Rivest R., Menard D., Gaudin D., Fournier A., et al. Neurobehavioral profile of neuropeptide Y. Brain Res. Bull. 26:1991;265-268
46. Bouali S.M., Fournier A., St-Pierre S., Jolicoeur F.B. In vivo central actions of NPY(1-30), an N-terminal fragment of neuropeptide Y. Peptides. 15:1994;799-802
47. Dhillo W.S., Small C.J., Stanley S.A., Jethwa P.H., Seal L.J., Murphy K.G., et al. Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte- stimulating hormone in vitro in male rats. J. Neuroendocrinol. 14:2002;725-730